T he weight-loss drug Zepbound (tirzepatide) now has another major benefit: on Dec. 20, it became the first drug approved by ...

Some traditional fairy tales and classic children's fiction that have soothed many a child to sleep may also provide ...

The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe ...

According to a Canadian study, these stories could also become excellent educational aids for teaching children the ...

Zepbound is the first prescription drug approved specifically to treat the common condition. The Food and Drug Administration ...

Sleep apnea may lead to increased brain growth in the hippocampus, which could have implications for memory and cognitive ...

US regulators on Friday approved the first drug treatment for sleep apnea, permitting the use of a weight-loss medication for the condition that affects millions of Americans.

A new study published in the journal of Sleep and Breathing showed that a higher risk of moderate-to-severe obstructive sleep ...

The FDA on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity.

A recent study published in the Journal Children found that nocturnal enuresis is significantly prevalent in children with ...

Sleep apnea – a disorder in which breathing stops and starts during the night – may cause damage to small blood vessels in ...